Latest Digene Stories
VENLO, The Netherlands, October 29, 2014 /PRNewswire/ -- - Achieved Q3 2014 targets: Adjusted net sales of $336.8 million (+4% CER); adjusted operating
GERMANTOWN, Md., April 16, 2014 /PRNewswire/ -- -- Investment of $10 million in Germantown and Frederick campuses brings QIAGEN's total recent commitment in Maryland to $50 million
KOLKATA, India, February 26, 2014 /PRNewswire/ -- - The careHPV(TM) Test is the first HPV diagnostic designed for regions with limited healthcare
VENLO, The Netherlands, January 29, 2014 /PRNewswire/ -- - Achieved 2013 targets: Adjusted net sales $1.31 billion (+5% CER), growth in all regions
- Withering but not falling off, as a blossom that persists on a twig after flowering.